Oxford, United Kingdom

Susan Marie Kingsman


Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 34(Granted Patents)


Location History:

  • Appleton, GB (2005 - 2010)
  • Oxford, GB (2004 - 2017)

Company Filing History:


Years Active: 2004-2017

Loading Chart...
10 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Susan Marie Kingsman**

Introduction

Susan Marie Kingsman is a distinguished inventor based in Oxford, GB, known for her groundbreaking work in the field of biotechnology. With an impressive portfolio of 10 patents, Kingsman has made significant strides in the development of innovative therapeutic solutions, particularly in cancer treatment and gene therapy.

Latest Patents

Among her latest innovations, one notable patent involves a viral vector that encompasses a multicistronic retroviral vector genome. This invention features a first nucleic acid sequence positioned upstream of at least one internal regulatory element, which enhances the level of genomic RNA available for packaging, even in the absence of Rev or its functional equivalents. Another significant patent includes the MHC class II epitopes of the 5T4 antigen, which proposes a peptide epitope designed to treat or prevent diseases, notably cancerous conditions. This patent outlines several minimal epitopes derived from specific amino acid sequences of the 5T4 antigen and suggests their use in vaccine development.

Career Highlights

Kingsman's contributions to the field stem from her experience with prominent companies such as Oxford Biomedica Limited and Oxford Biomedia Limited. Her expertise in molecular biology and immunology has positioned her as a key figure in providing innovative solutions to complex medical challenges.

Collaborations

Throughout her career, Kingsman has collaborated with several esteemed professionals, including Miles William Carroll and Alan John Kingsman. These partnerships have enabled her to further research and develop cutting-edge therapies that aim to improve patient outcomes, particularly in oncology.

Conclusion

Susan Marie Kingsman's inventive prowess continues to make waves in the biotechnology sector, with her patents reflecting her commitment to advancing medical science. Her work is critical in the ongoing quest for effective treatments, particularly against cancer, and her legacy will undoubtedly inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…